Blueprint Medicines Corporation

DB:2L9 Stock Report

Market Cap: €5.7b

Blueprint Medicines Corporation Company Information

Blueprint Medicines Corporation's employee growth, exchange listings and data sources

Key Information

  • Name: Blueprint Medicines Corporation
  • Ticker: 2L9
  • Exchange: DB
  • Founded: 2008
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$5.963b
  • Listing Market Cap: US$5.692b
  • Shares Outstanding: 63.53m
  • Website: https://www.blueprintmedicines.com

Number of Employees

Location

  • Blueprint Medicines Corporation
  • 45 Sidney Street
  • Cambridge
  • Massachusetts
  • 02139
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
BPMCNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDApr 2015
2L9DB (Deutsche Boerse AG)YesCommon StockDEEURApr 2015
0HOJLSE (London Stock Exchange)YesCommon StockGBUSDApr 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/26 09:36
End of Day Share Price 2024/11/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.